Search for: "VALEANT PHARMACEUTICALS INTERNATIONAL" Results 1 - 20 of 51
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jul 2007, 9:44 pm
By Donald Zuhn -- Valeant Pharmaceuticals International announced today (July 2, 2007) that it has settled its patent infringement suit with Kali Laboratories, Inc. [read post]
30 Mar 2011, 10:39 am by Brian Baxter
Valeant Pharmaceuticals International unveiled a hostile $5.7 billion cash bid for U.S. drugmaker Cephalon on Tuesday. [read post]
29 Mar 2011, 3:23 pm by By MICHAEL J. DE LA MERCED
Valeant Pharmaceuticals International offered to buy Cephalon for $5.7 billion in cash on Tuesday, kicking off a hostile bid for its smaller competitor after weeks of discussions failed to produce a deal. [read post]
23 May 2018, 6:46 am by Lindsay Offutt
Valeant is a pharmaceutical manufacturer and Philidor is a specialty mail-order pharmaceutical company. [read post]
31 Mar 2016, 7:02 am by Robert Kraft
Elijah Cummings (D-MD) released two memos detailing key findings from over 250,000 pages of documents provided to the House Oversight and Government Reform Committee by Turing Pharmaceuticals and another 75,000 by Valeant. [read post]
17 Jan 2018, 5:58 am by John Jascob
Valeant Pharmaceuticals International, Inc., January 12, 2018, Shipp, M.).The complaints are direct actions under Sections 10(b), 18(a), and 20(a) of the Exchange Act, not to be confused with the class action pending before the same court and arising out of the same facts and circumstances. [read post]
21 Feb 2019, 9:29 pm by Patent Docs
As set forth in the beginning of the opinion: Valeant Pharmaceuticals International, Inc. [read post]
11 Jul 2012, 9:50 pm by Patent Docs
Valeant International (Barbados) SRL v. [read post]
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
8 Feb 2017, 5:45 am
Allergan Inc. has agreed with the SEC that it will admit to securities law violations and will pay a $15 million fine for disclosure violations in its Schedule 14D-9 relating to the unsolicited, public takeover bid for the company made by Valeant Pharmaceuticals International in 2014. [read post]
13 May 2014, 5:00 am by Gene Quinn
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
13 May 2014, 5:00 am by Gene Quinn
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
26 Apr 2012, 9:18 pm by Patent Docs
.; Valeant International (Barbados) SRL • Defendants: Watson Laboratories Inc. [read post]
1 Apr 2016, 6:00 am by Doug Cornelius
Valeant may get bank waivers but risks default with SEC and NYSE by Francine McKenna in MarketWatch Valeant Pharmaceuticals International Inc. may get a waiver from its bank lenders to file its Form 10-K annual report and first-quarter report later than required. [read post]